Table 3.
Treatment and outcome in ten cases with intraocular inflammation due to B. henselae and B. Quintana
|
VA (before treatment) |
VA (after treatment) |
Treatment | Follow-up (years) | Complications | ||
|---|---|---|---|---|---|---|
| RE | LE | RE | LE | |||
| 1.0 | 0.05 | 1.0 | 0.025 | Ciprofloxacin 750 mg (daily) Doxycycline 100 mg (12-hourly) 4 weeks Followed by (IV) Ceftriaxone 1 g (12-hourly) 1 week |
6 | AION (arteritic) RE, TINU Final VA RE: CF/30 cm |
| 0.5 | 1.0 | 1.0 | 1.0 | Rifampicin 600 mg (daily) Doxycycline 100 mg (12-hourly) 4 weeks |
7 | Chorioretinal scar RE (extrafoveal) |
| 0.9 | 0.8 | 1.0 | 1.0 | Rifampicin 600 mg (daily) Azithromycin 500 mg (daily) 4 weeks |
5 | Myocarditis (1 year after the onset of the ocular disease) |
| 1.0 | 0.8 | 1.0 | 1.0 | Rifampicin 600 mg (daily) Azithromycin 500 mg (daily) 4 weeks |
2.5 | |
| 1.0 | 0.5 | 1.0 | 1.0 | Ciprofloxacin 500 mg (12-hourly) 4 weeks | 7 | ERM of the macula (VA LE: 1.0 → 0.9) |
| 0.6 | 0.8 | 1.0 | 1.0 | Rifampicin 600 mg (daily) Doxycycline 100 mg (12-hourly) 4 weeks |
1 | |
| 0.7 | 0.8 | 1.0 | 1.0 | Rifampicin 600 mg (daily) Doxycycline 100 mg (12-hourly) 4 weeks |
2 | ERM of the macula (VA RE: 1.0 → 0.8) |
| 0.9 | 0.9 | 1.0 | 1.0 | Rifampicin 600 mg (daily) Doxycycline 100 mg (12-hourly) 4 weeks |
2 | |
| 1.0 | 0.8 | 1.0 | 1.0 | Doxycycline 100 mg (12-hourly) Azithromycin 500 mg (daily) 4 weeks |
3 | Cataract formation (VA LE: 1.0 → 0.9) |
| 0.7 cataract | 0.4 | 0.7 cataract | 0.9 | Rifampicin 600 mg (daily) Doxycycline 100 mg (12-hourly) 4 weeks |
1 | |
Note: The visual acuities in bold italics concern the affected eyes.
Abbreviations: R, rifampicin; D, doxycycline; A, azithromycin; IV, intravenous; AION, anterior ischemic optic neuropathy; TINU, tubular interstitial nephritis and uveitis; ERM, epiretinal membrane; VA, visual acuity, RE, right eye; LE, left eye.